Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Canada Clear all

256 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20023
20037
20046
200512
200611
20077
200821
200913
201030
201114
201218
201315
20149
20157
20168
201713
20187
20199
20202
20216
20224
20235
20244
20253
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed210
Terminated23
Recruiting14
Active, not recruiting7
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S53
AstraZeneca42
Boehringer Ingelheim26
Sanofi22
Eli Lilly and Company16
Hoffmann-La Roche10
Lexicon Pharmaceuticals8
Janssen Research & Development, LLC7
Takeda7
GlaxoSmithKline6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2256
Diabetes Mellitus73
Obesity15
Cardiovascular Diseases13
Glucose Metabolism Disorders11
Metabolic Diseases10
Overweight10
Endocrine System Diseases9
Hypertension8
Insulin Resistance7

Trials

Showing 1 to 25 of 256. Each trial links to its page on Pharma Observatory.

156 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.